GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » EV-to-EBITDA

Centene (Centene) EV-to-EBITDA

: 7.03 (As of Today)
View and export this data going back to 2001. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Centene's enterprise value is $39,653 Mil. Centene's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $5,637 Mil. Therefore, Centene's EV-to-EBITDA for today is 7.03.

The historical rank and industry rank for Centene's EV-to-EBITDA or its related term are showing as below:

CNC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.96   Med: 9.53   Max: 18.46
Current: 7.03

During the past 13 years, the highest EV-to-EBITDA of Centene was 18.46. The lowest was 5.96. And the median was 9.53.

CNC's EV-to-EBITDA is ranked better than
66.67% of 15 companies
in the Healthcare Plans industry
Industry Median: 8.56 vs CNC: 7.03

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-23), Centene's stock price is $75.58. Centene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $4.910. Therefore, Centene's PE Ratio for today is 15.39.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Centene EV-to-EBITDA Historical Data

The historical data trend for Centene's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.78 8.30 14.75 12.88 6.95

Centene Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.88 8.97 6.55 6.27 6.95

Competitive Comparison

For the Healthcare Plans subindustry, Centene's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centene EV-to-EBITDA Distribution

For the Healthcare Plans industry and Healthcare sector, Centene's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Centene's EV-to-EBITDA falls into.



Centene EV-to-EBITDA Calculation

Centene's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=39653.182/5637
=7.03

Centene's current Enterprise Value is $39,653 Mil.
Centene's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,637 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centene  (NYSE:CNC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Centene's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=75.58/4.910
=15.39

Centene's share price for today is $75.58.
Centene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.910.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Centene EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Centene's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Centene (Centene) Business Description

Address
7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Executives
Lori Jean Robinson director 5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher officer: EVP, CFO 8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray officer: EVP, Chief Transform. Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii director 1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford director C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola officer: EVP, Health Care Enterprises 500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley officer: EVP, Chief Admin. Officer 7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt director 822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin director
H James Dallas director 127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks officer: SVP, Chief Information Officer 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas officer: EVP, MARKETS 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A officer: EVP, Mergers & Acquisitions 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105

Centene (Centene) Headlines

From GuruFocus

Q3 2022 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Centene Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Centene Corp June Investor Update (Virtual) Transcript

By GuruFocus Research 01-22-2024

Q1 2023 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024